WHO’s “Balanced National Controlled Medicine Policies to Ensure Medical Access and Safety”
The World Health Organization has brought out renewed guidelines on “Balanced National Controlled Medicine Policies to Ensure Medical Access and Safety”. As is said in the introduction to the guidelines, “The purpose of this guideline is to assist WHO Member States and their partners in developing and implementing balanced national controlled medicines policies to ensure their accessibility, availability and affordability for medical and scientific uses and to minimize the risk of harm arising from non-medical use”.Guidelines like this can never be the best fit for every country. The guidelines had to be evidence-based, but unfortunately, there is so precious little evidence generated in Low and Middle Income Countries (LMICs). Nevertheless, having had a member of the Guideline Development Committee (GDG) from Pallium India, we have been able to put forth the LMIC-views. The ’strong recommendations’ had to be evidence-based; but even when evidence is limited, the “Good Practice Statements” would offer valuable guidance.
Click Here to view the document.
Comments are closed.
